Answers are grounded in this paper and cite their sources.
Scalp reconstruction in neuro-oncology patients undergoing repeat craniotomy is complicated by cumulative tissue injury, resulting in high-tension closures and increased risk of wound complications. While acellular dermal matrices (ADM) have been used in reconstructive surgery, their role in this population remains incompletely characterized. We report our experience using ADM to facilitate galea tension relief and soft tissue augmentation in this setting. We performed a retrospective review of 23 neuro-oncology cases (2017–2022) in which ADM was used during scalp closure following cranial surgery. Patient demographics, treatment history, operative characteristics, and postoperative outcomes were collected. Primary outcomes included treated and/or eroded scalp, exposed cranioplasty and/or hardware, surgical site infection, and reoperation for any of the aforementioned complications. Patients had a mean age of 57.8 years, with nearly all patients having prior cranial surgery and radiotherapy. Multiple prior surgeries were present in 34.8%, and 13.0% had prior infection. ADM was used to facilitate tension-free closure in all patients, covering a mean area of 83.0 ± 30.0 cm². Mean follow-up was 18.2 ± 19.4 months. One patient (4.3%) developed a wound complication requiring reoperation for hardware exposure. All other ADM-assisted closures remained intact, including in patients undergoing subsequent surgery or radiotherapy. ADM-assisted closure appears to be a safe and effective adjunct for managing high-tension scalp wounds in neuro-oncology patients with compromised soft tissue. Its use may mitigate wound morbidity and broaden reconstructive options in previously treated fields.
No takes yet. Share an insight, caveat, or question.
Nutter et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: